Liu L - Search Results

1

miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression.

Liu L, Ning Y, Yi J, Yuan J, Fang W, Lin Z, Zeng Z. Liu L, et al. Biomed Pharmacother. 2020 May;125:109865. doi: 10.1016/j.biopha.2020.109865. Epub 2020 Feb 12. Biomed Pharmacother. 2020. PMID: 32058212 Free article.

2

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer.

Yao T, Rao Q, Liu L, Zheng C, Xie Q, Liang J, Lin Z. Yao T, et al. Among authors: liu l. Virol J. 2013 Jun 3;10:175. doi: 10.1186/1743-422X-10-175. Virol J. 2013. PMID: 23732000 Free PMC article.

3

Biological characteristics and construction of stable ALDH-1 knock-down Hela cell lines.

Liu L, Yi J, Zhang D, Zhang D, Chen S, Li X, Qin J, Wang M, Wang M, Lin Z. Liu L, et al. Eur J Gynaecol Oncol. 2016;37(3):357-61. Eur J Gynaecol Oncol. 2016. PMID: 27352564

4

Expression and clinical significance of transcription factor 4 (TCF4) in epithelial ovarian cancer.

Liu L, Zeng Z, Yi J, Zuo L, Lv J, Yuan J, Lin Z, Luo R, Feng X. Liu L, et al. Cancer Biomark. 2019;24(2):213-221. doi: 10.3233/CBM-181849. Cancer Biomark. 2019. PMID: 30614797

5

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer.

Liu L, Yi J, Deng X, Yuan J, Zhou B, Lin Z, Zeng Z. Liu L, et al. Oncol Lett. 2019 Aug;18(2):1049-1056. doi: 10.3892/ol.2019.10406. Epub 2019 May 27. Oncol Lett. 2019. PMID: 31423165 Free PMC article.

6

Low expression of KIF7 indicates poor prognosis in epithelial ovarian cancer.

Yao Y, Liu L, He W, Lin X, Zhang X, Lin Z, Zeng Z, Guo S. Yao Y, et al. Among authors: liu l. Cancer Biomark. 2019;26(4):481-489. doi: 10.3233/CBM-190328. Cancer Biomark. 2019. PMID: 31658044

7

LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.

Zeng Z, Ji N, Yi J, Lv J, Yuan J, Lin Z, Liu L, Feng X. Zeng Z, et al. Among authors: liu l. Cancer Biomark. 2020;28(1):65-72. doi: 10.3233/CBM-191145. Cancer Biomark. 2020. PMID: 32176632

8

FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancer.

Liu L, Yi J, Yuan J, Yao T, Lin Z, Ning Y, Zeng Z. Liu L, et al. Cancer Biomark. 2020;28(1):1-8. doi: 10.3233/CBM-182119. Cancer Biomark. 2020. PMID: 32224523

9

Expression and Clinical Significance of Microtubule-Actin Cross-Linking Factor 1 in Serous Ovarian Cancer.

Liu L, Hu K, Zeng Z, Xu C, Lv J, Lin Z, Wen B. Liu L, et al. Recent Pat Anticancer Drug Discov. 2021;16(1):66-72. doi: 10.2174/1574892816666210211091543. Recent Pat Anticancer Drug Discov. 2021. PMID: 33573562

10

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Ning Y, Zeng Z, Deng Y, Feng W, Huang L, Liu H, Lin J, Zhang C, Fan Y, Liu L. Ning Y, et al. Among authors: liu h, liu l. Cancer Sci. 2021 May;112(5):1785-1797. doi: 10.1111/cas.14864. Epub 2021 Mar 31. Cancer Sci. 2021. PMID: 33788346 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74,162 results

Search Page

Filters